17 days ago
RYTM
AnalystsSeamus FernandezSeamus Fernandez's Stock Forecasts
AnalystsSeamus Fernandez
Analyst Ranking
Top 2%
#93 out of 5217 analysts
Average Return
+60.81%
Win Rate
59%48 out of 81
Risk vs Reward
Poor
Good
Seamus Fernandez's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,088.30% | $18.63 | $221.38 | 2025-05-08 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +768.16% | $25.50 | $221.38 | 2025-05-15 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +673.26% | $13.50 | $104.39 | 2024-11-07 - 2025-11-07 | Strong Buy |
Cidara Therapeutics IncCDTX | +372.63% | $46.84 | $221.38 | 2025-06-23 - 2026-01-06 | Strong Buy |
Mbx Biosciences IncMBX | +346.57% | $6.27 | $28.00 | 2025-04-09 - 2026-03-13 | Strong Buy |
Seamus Fernandez Analyst Color
Get additional color on Seamus Fernandez's coverage of popular stocks
2 months ago
LLY
2 months ago
GPCR
2 months ago
MBX
3 months ago
TENX
3 months ago
RYTM
3 months ago
BMY
5 months ago
LLY
6 months ago
CDTX
6 months ago
MBX
6 months ago
AMLX
9 months ago
CDTX
10 months ago
CDTX
10 months ago
CDTX
a year ago
LLY
a year ago
APGE
2 years ago
LLY
2 years ago
APGE
2 years ago
APGE
3 years ago
MRK
3 years ago
LLY
4 years ago
MRK
Seamus Fernandez's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | 1 | Strong Buy | $35.00 | +53.85% | Maintains | 17 days ago |
Rhythm Pharmaceuticals IncRYTM | 4 | Strong Buy | $143.00 | +63.65% | Maintains | 17 days ago |
Bristol Myers Squibb CoBMY | 7 | Strong Buy | $72.00 | +21.87% | Maintains | a month ago |
Sagimet Biosciences IncSGMT | 1 | Strong Buy | $27.00 | +418.23% | Initiates Coverage On | a month ago |
Vaxcyte IncPCVX | 5 | Strong Buy | $116.00 | +112.53% | Reiterates | a month ago |
Eli Lilly & CoLLY | 15 | Strong Buy | $1,161.00 | +17.86% | Maintains | 2 months ago |
Structure Therapeutics IncGPCR | 3 | Strong Buy | $140.00 | +160.47% | Maintains | 2 months ago |
Mbx Biosciences IncMBX | 5 | Strong Buy | $88.00 | +214.29% | Maintains | 2 months ago |
Tenax Therapeutics IncTENX | 3 | Strong Buy | $25.00 | +80.64% | Maintains | 3 months ago |
Inventiva SaIVA | 1 | Strong Buy | $11.00 | +83.64% | Maintains | 4 months ago |
Cidara Therapeutics IncCDTX | 5 | Strong Buy | $167.00 | -24.56% | Maintains | 6 months ago |
Amylyx Pharmaceuticals IncAMLX | 2 | Strong Buy | $25.00 | +78.70% | Maintains | 6 months ago |
Apogee Therapeutics IncAPGE | 6 | Strong Buy | $116.00 | +61.34% | Reiterates | 8 months ago |
Metsera IncMTSR | 1 | Strong Buy | $56.00 | N/A | Initiates Coverage On | a year ago |
Merck & Co IncMRK | 9 | Strong Buy | $122.00 | N/A | Maintains | a year ago |
Icosavax IncICVX | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 2 years ago |
Hillevax IncHLVX | 2 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Verve Therapeutics IncVERV | 1 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | $36.00 | N/A | Reiterates | 3 years ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 3 years ago |
Dice Therapeutics IncDICE | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 3 years ago |
Altimmune IncALT | 2 | Strong Buy | $26.00 | N/A | Maintains | 4 years ago |
Albireo Pharma IncALBO | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 4 years ago |
Invivyd IncIVVD | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Novartis AgNVS | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Dermira IncDERM2 | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Tesaro IncTSRO | 4 | Hold | $75.00 | N/A | Downgrades | 7 years ago |
Intra Cellular Therapies IncITCI | 3 | Buy | $27.00 | N/A | Initiates Coverage On | 7 years ago |
Allergan PLCAGN | 3 | Buy | $220.00 | N/A | Initiates Coverage On | 7 years ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $54.00 | N/A | Maintains | 8 years ago |
Celldex Therapeutics IncCLDX | 2 | Hold | $45.00 | N/A | Maintains | 8 years ago |
Astrazeneca PLCAZN | 2 | Hold | $38.00 | N/A | Maintains | 8 years ago |
Pfizer IncPFE | 1 | Hold | $38.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.